Development

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Articles

Roche voluntarily recalled Susvimo’s ocular implant, insertion tool, and initial fill kit when test results did not satisfy company standards.

Roche to Reintroduce nAMD Treatment in US After FDA Approves Updates

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The biggest hurdle is developing palatable formulations that are efficacious and patient friendly. 


Overcoming Challenges to Formulation Development for Pediatric Medicines

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

It is possible to overcome some of the limitations of traditional dosage forms by employing alternative drug delivery formulation strategies.

Delivering a Difference in Formulation

Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.

Sanofi Announces €300 million Collaboration with Blackstone Life Sciences to Advance a Treatment for Multiple Myeloma

AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers as part of AstraZeneca’s Ambition Zero Carbon program. 

AstraZeneca Progresses Ambition Zero Carbon Program with Honeywell Partnership to Develop Next-Generation Respiratory Inhalers

ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.

SAHPRA Authorizes ImmunityBio to Proceed with Trial of T-Cell Vaccine as Booster Against COVID-19

UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.

SPI Pharma Introduces Platform for Orally Disintegrating Tablets

Torkel Gren is senior director, Technology Officer & Strategic Investments at Recipharm.

Modified-release dosage forms present new opportunities for drug developers and can help overcome challenges, such as short biological half-life or poor bioavailability due to degradation in the stomach. 

Modified Release: A Pathway to More Patient-Friendly Medication

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.

Combining Multiparticulates and 3DP for Patient-Centric Dosage Forms

Equipment and process optimization must be considered for scaling up these developmental technologies to commercial production.

Formulation and Drug Delivery, Specialty Dosage Forms